Bernard H. Bochner

40.6k total citations · 7 hit papers
338 papers, 17.6k citations indexed

About

Bernard H. Bochner is a scholar working on Surgery, Urology and Oncology. According to data from OpenAlex, Bernard H. Bochner has authored 338 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Surgery, 97 papers in Urology and 62 papers in Oncology. Recurrent topics in Bernard H. Bochner's work include Bladder and Urothelial Cancer Treatments (274 papers), Urinary and Genital Oncology Studies (176 papers) and Urological Disorders and Treatments (88 papers). Bernard H. Bochner is often cited by papers focused on Bladder and Urothelial Cancer Treatments (274 papers), Urinary and Genital Oncology Studies (176 papers) and Urological Disorders and Treatments (88 papers). Bernard H. Bochner collaborates with scholars based in United States, Canada and United Kingdom. Bernard H. Bochner's co-authors include Guido Dalbagni, Harry W. Herr, S. Machele Donat, Donald G. Skinner, Susan Groshen, John P. Stein, Gary Lieskovsky, Eila C. Skinner, Andrew J. Vickers and Stuart D. Boyd and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Bernard H. Bochner

319 papers receiving 17.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

2001 2.6k citations John P. Stein, Gary Lieskovsky et al. Journal of Clinical Oncology profile →
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

2008 1.0k citations Bernard H. Bochner, Guido Dalbagni et al. European Urology profile →
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

2017 613 citations Bernard H. Bochner, Ashish M. Kamat et al. profile →
The mechanism of action of BCG therapy for bladder cancer—a current perspective

2014 522 citations Bernard H. Bochner et al. profile →
Genome Sequencing Identifies a Basis for Everolimus Sensitivity

2012 480 citations Gopa Iyer, Aphrothiti J. Hanrahan et al. Science profile →
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

2014 401 citations Bernard H. Bochner, Guido Dalbagni et al. European Urology profile →
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)

2018 397 citations Bernard H. Bochner, Seth P. Lerner et al. European Urology profile →

Peers

Countries citing papers authored by Bernard H. Bochner

Since Specialization

Citations

This map shows the geographic impact of Bernard H. Bochner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard H. Bochner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard H. Bochner more than expected).

Fields of papers citing papers by Bernard H. Bochner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard H. Bochner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard H. Bochner. The network helps show where Bernard H. Bochner may publish in the future.

Co-authorship network of co-authors of Bernard H. Bochner

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard H. Bochner. A scholar is included among the top collaborators of Bernard H. Bochner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard H. Bochner. Bernard H. Bochner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COMUTATIONAL PATTERNS IN FGFR3-ALTERED NON-MUSCLE INVASIVE BLADDER CANCER INFLUENCE RECURRENCE AND PROGRESSION 2024 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), (unknown), Sizhi Paul Gao, (unknown), Alvin C. Goh, Bernard H. Bochner, David B. Solit, Gopa Iyer, Hikmat Al‐Ahmadie, Eugene J. Pietzak, (unknown)	0
2	Abstract PR005: Final results from a Phase I trial of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin (BCG) for patients with BCG-exposed high-grade non-muscle invasive bladder cancer 2024 ·Clinical Cancer Research ·(unknown), Christopher Gaffney, Jessica A. Lavery, (unknown), (unknown), (unknown), (unknown), Patricia Morán, (unknown), (unknown), Daniel D. Sjoberg, Guido Dalbagni, Timothy R. Donahue, S. Machele Donat, Dean F. Bajorin, Bernard H. Bochner, Alvin C. Goh, Judy Sarungbam, Hikmat Al‐Ahmadie, Eugene J. Pietzak	0
3	Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies 2023 ·Cancers ·Oğuz Akın, (unknown), Ramesh Paudyal, Amaresha Shridhar Konar, Thomas L. Chenevert, Dariya Malyarenko, Lubomir M. Hadjiiski, Hikmat Al‐Ahmadie, Alvin C. Goh, Bernard H. Bochner, Jonathan E. Rosenberg, Lawrence H. Schwartz, Amita Shukla‐Dave	8
4	A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology 2023 ·Tomography ·Eve LoCastro, Ramesh Paudyal, Amaresha Shridhar Konar, Peter S. LaViolette, Oğuz Akın, Vaios Hatzoglou, Alvin C. Goh, Bernard H. Bochner, Jonathan E. Rosenberg, Richard J. Wong, Nancy Y. Lee, Lawrence H. Schwartz, Amita Shukla‐Dave	4
5	Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma 2021 ·British Journal of Cancer ·Min Yuen Teo, Hikmat Al‐Ahmadie, Kenneth Seier, (unknown), Ashley Marie Regazzi, Eugene J. Pietzak, David B. Solit, Satish K. Tickoo, Victor E. Reuter, K. Eugene, Harry W. Herr, Timothy F. Donahue, S. Machele Donat, Guido Dalbagni, Bernard H. Bochner, Samuel A. Funt, Gopa Iyer, Dean F. Bajorin, Irina Ostrovnaya, Jonathan E. Rosenberg	21
6	Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer 2021 ·Clinical Cancer Research ·Jeffrey S. Damrauer, Kyle R. Roell, (unknown), Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley, Halei C. Benefield, Gopa Iyer, David B. Solit, Matthew I. Milowsky, William Y. Kim, Matthew E. Nielsen, Sara E. Wobker, Guido Dalbagni, Hikmat Al‐Ahmadie, Andrew F. Olshan, Bernard H. Bochner, Helena Furberg, Melissa A. Troester, Eugene J. Pietzak	33
7	Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails 2019 ·European Urology ·Marco Moschini, Shahrokh F. Shariat, Peter C. Black, Ashish M. Kamat, Armando Stabile, Xavier Cathelineau, Wassim Kassouf, Bernard H. Bochner, Évanguelos Xylinas, Morgan Rouprêt, Stephen A. Boorjian, James W.F. Catto, Rafael Sanchez‐Salas	4
8	DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma 2017 ·Clinical Cancer Research ·Min Yuen Teo, Richard Bambury, Emily C. Zabor, Emmet Jordan, Hikmat Al‐Ahmadie, Mariel Elena Boyd, Nancy Bouvier, Stephanie A. Mullane, K. Eugene, Nitin Roper, Irina Ostrovnaya, David M. Hyman, Bernard H. Bochner, Maria E. Arcila, David B. Solit, Michael F. Berger, Dean F. Bajorin, Joaquim Bellmunt, Gopa Iyer, Jonathan E. Rosenberg	189
9	Next‐generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non–muscle‐invasive urothelial carcinoma treated with bacille Calmette‐Guérin 2017 ·Cancer Cytopathology ·Sasinya N. Scott, Irina Ostrovnaya, (unknown), Nancy Bouvier, Bernard H. Bochner, Gopa Iyer, David B. Solit, Michael F. Berger, Oscar Lin	23
10	Male Neobladder 2017 ·Urologic Clinics of North America ·Eugene J. Pietzak, Timothy F. Donahue, Bernard H. Bochner	4
11	Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063) 2017 ·Bladder Cancer ·Guido Dalbagni, Nicole Benfante, Daniel D. Sjoberg, Bernard H. Bochner, S. Machele Donat, Harry W. Herr, (unknown), (unknown), (unknown), Jonathan E. Rosenberg, Dean F. Bajorin	17
12	Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes 2014 ·Clinical Imaging ·Pier Luigi Di Paolo, Hebert Alberto Vargas, Christoph Karlo, Yulia Lakhman, Junting Zheng, Chaya S. Moskowitz, Hikmat Al‐Ahmadie, Evis Sala, Bernard H. Bochner, Hedvig Hricak	17
13	Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer 2012 ·Clinical Cancer Research ·Markus Riester, Jennifer M. Taylor, Andrew Feifer, Theresa M. Koppie, Jonathan E. Rosenberg, Robert J. Downey, Bernard H. Bochner, Franziska Michor	177
14	Genome Sequencing Identifies a Basis for Everolimus Sensitivity breakdown → 2012 ·Science ·Gopa Iyer, Aphrothiti J. Hanrahan, Matthew I. Milowsky, Hikmat Al‐Ahmadie, Sasinya N. Scott, Manickam Janakiraman, Mono Pirun, Chris Sander, Nicholas D. Socci, Irina Ostrovnaya, Agnès Viale, Adriana Heguy, (unknown), Timothy A. Chan, Bernard H. Bochner, Dean F. Bajorin, Michael F. Berger, Barry S. Taylor, David B. Solit	480
15	A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer 2012 ·European Urology ·Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. Galsky, Noah M. Hahn, Seth P. Lerner, Malcolm Mason, Thomas Powles, Cora N. Sternberg, Guru Sonpavde	168
16	Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer 2012 ·European Journal of Radiology ·Hebert Alberto Vargas, Oğuz Akın, Heiko Schöder, Semra Olgac, Guido Dalbagni, Hedvig Hricak, Bernard H. Bochner	52
17	Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer 2006 ·Journal of Clinical Oncology ·(unknown), Bernard H. Bochner, Michael W. Kattan	344
18	Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients breakdown → 2001 ·Journal of Clinical Oncology ·John P. Stein, Gary Lieskovsky, Rick Cote, Susan Groshen, An‐Chen Feng, Stuart D. Boyd, Eila C. Skinner, Bernard H. Bochner, (unknown), Maged Mikhail, Derek Raghavan, Donald G. Skinner	2645
19	Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis 1995 ·JNCI Journal of the National Cancer Institute ·Bernard H. Bochner, R. J. Cote, Noel Weidner, Susan Groshen, (unknown), Donald G. Skinner, Peter W. Nichols	353
20	Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma 1992 ·Journal of Surgical Research ·(unknown), Bernard H. Bochner, (unknown), Alec S. Koo, Jean B. deKernion, Arie S. Belldegrun	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact